Infection

 
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 8, 2021
October 08, 2021

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

AstraZeneca Submits Request for EUA for COVID-19 Prophylaxis, AZD7442
October 08, 2021

This week, AstraZeneca submitted a request to the FDA for an emergency use authorization for their long-acting antibody cocktail for prophylaxis of COVID-19.

COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 7, 2021
October 07, 2021

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 6, 2021
October 06, 2021

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 5, 2021
October 05, 2021

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

COVID-19 Lockdown Had Significant, Yet Varying, Impact on Glycemic Control
October 04, 2021

EASD 2021: First analysis of its kind found COVID-19-induced lockdown was associated with improved glycemic control among patients with T1D, but not T2D.

COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 4, 2021
October 04, 2021

The number of US confirmed deaths has surpassed 702 000. Plus more data on the Delta variant, cases, mortalities, and vaccination in our daily update.

COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 1, 2021
October 01, 2021

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Merck Oral Antiviral Reduces by Half the Risk of COVID-19 Hospitalization, Death in Vulnerable Adults
October 01, 2021

The positive results of the Merck MOVe-OUT phase 3 interim analysis of molnupiravir have led to an early halt to study recruitment, the company said Friday.

People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
October 01, 2021

Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.